Oral nanoparticles based on gellan gum/pectin for colon-targeted delivery of resveratrol

dc.contributor.authorPrezotti, Fabíola Garavello [UNESP]
dc.contributor.authorBoni, Fernanda Isadora [UNESP]
dc.contributor.authorFerreira, Natália Noronha [UNESP]
dc.contributor.authorSilva, Daniella Souza
dc.contributor.authorAlmeida, Andreia
dc.contributor.authorVasconcelos, Teófilo
dc.contributor.authorSarmento, Bruno
dc.contributor.authorGremião, Maria Palmira Daflon [UNESP]
dc.contributor.authorCury, Beatriz Stringhetti Ferreira [UNESP]
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.contributor.institutionUniversidade de São Paulo (USP)
dc.contributor.institutionUniversidade do Porto
dc.contributor.institutionCESPU-Instituto de Investigação e Formação Avançada em Ciências e Tecnologias da Saúde
dc.date.accessioned2020-12-12T02:34:00Z
dc.date.available2020-12-12T02:34:00Z
dc.date.issued2020-02-01
dc.description.abstractNanoparticles based on gellan gum/pectin blends were designed for colon-targeted release of resveratrol (RES). Their impact on drug release rates and permeability were evaluated using Caco-2 cell model and mucus secreting triple co-culture model. Polymeric nanoparticles (PNP) were successfully prepared by nebulization/ionotropic gelation, achieving high drug loading (>80%). PNP were spherical with a low positive charge density (+5mV) and exhibited diameters of around 330 nm. Developed PNP were able to promote effective modulation of drug release rates, so that only 3% of RES was released in acidic media over 2 h, and, in pH 6.8, the drug was released in a sustained manner, reaching 85% in 30 h. The permeability of RES-loaded PNP in the Caco-2 model was 0.15%, while in the triple co-culture model, in the presence of mucus, it reached 5.5%. The everted gut sac experiment corroborated the low permeability of RES-loaded PNP in the presence or absence of mucus and highlighted their high ability to interact with the intestinal tissue. Results indicate that the novel PNP developed in this work are safe and promising carriers for controlled delivery of RES at the colon.en
dc.description.affiliationSchool of Pharmaceutical Sciences São Paulo State University (UNESP)
dc.description.affiliationChemistry Institute of São Carlos São Paulo University (USP)
dc.description.affiliationI3S-Instituto de Investigação e Inovação em Saúde Universidade do Porto
dc.description.affiliationINEB-Instituto de Engenharia Biomédica Universidade do Porto
dc.description.affiliationCESPU-Instituto de Investigação e Formação Avançada em Ciências e Tecnologias da Saúde
dc.description.affiliationUnespSchool of Pharmaceutical Sciences São Paulo State University (UNESP)
dc.format.extent236-245
dc.identifierhttp://dx.doi.org/10.1080/03639045.2020.1716374
dc.identifier.citationDrug Development and Industrial Pharmacy, v. 46, n. 2, p. 236-245, 2020.
dc.identifier.doi10.1080/03639045.2020.1716374
dc.identifier.issn1520-5762
dc.identifier.issn0363-9045
dc.identifier.scopus2-s2.0-85078402703
dc.identifier.urihttp://hdl.handle.net/11449/201495
dc.language.isoeng
dc.relation.ispartofDrug Development and Industrial Pharmacy
dc.sourceScopus
dc.subjectcaco-2 cells
dc.subjectcolon-targeted release
dc.subjecteverted gut sac
dc.subjectin vitro permeability
dc.subjectPolymeric nanoparticles
dc.subjecttriple co-culture model
dc.titleOral nanoparticles based on gellan gum/pectin for colon-targeted delivery of resveratrolen
dc.typeArtigo
unesp.author.orcid0000-0001-5763-7553[7]
unesp.departmentFármacos e Medicamentos - FCFpt

Arquivos